AcoArt Ⅰ / SFA China
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT01850056
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01850056
-
- Other papers using this trial's data
- Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01850056. Randomized; single masking; primary purpose treatment. Start 2013-04 (actual); primary completion 2016-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AcoArt Ⅰ / SFA China
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- drug eluting balloon catheter (trade name: Orchid)
- Intervention (Device)
- common percutaneous transluminal angioplasty balloon catheter (trade name: Admiral)
- Lead sponsor
- Acotec Scientific Co., Ltd
Record details
- Record id
cardio:ct-nct01850056- Content hash
d52c257b23ca9f5c2b4c0e3f8ef306a4e192eff66b714f337d28edfe1bff6701